Accordingly, SIRT3 inhibited the ability of Ara‐C to induce mitochondria ROS, which was associated with acquired chemoresistance to the drug (Fig 4D), and was similar to the findings in the primary AML cells. This evidence concerns the gene SIRT3 and acute myeloid leukemia.